Workflow
A股普通股股票
icon
Search documents
百花医药: 新疆百花村医药集团股份有限公司2021年股票期权激励计划行权结果暨股份变动公告
Zheng Quan Zhi Xing· 2025-08-21 09:13
新疆百花村医药集团股份有限公司 证券代码:600721 证券简称:百花医药 编号:2025-031 新疆百花村医药集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要提示 ? 本次行权股票数量:2025 年 7 月 1 日至 2025 年 7 月 31 日,新疆百花村 医药集团股份有限公司(以下简称"公司")2021 年股票期权激励计划首次 授予股票期权第三个行权期、预留授予股票期权第二个行权期激励对象共行权 并完成股份过户登记 253,760 股,占可行权股票期权总量的 10.02%。截至 2025 年 7 月 31 日累计行权并完成股份过户登记 2,459,205 股,占可行权股票期权总 量的 97.08%。 ? 本次行权股票上市流通时间:公司 2021 年股票期权激励计划采用自主行 权方式,激励对象行权股票于行权日(T 日)后第二个交易日(T+2)日上市 交易。 一、本次股票期权行权的决策程序及相关信息披露 通过《关于公司〈2021 年股票期权激励计划(草案)〉及其摘要的议案》《关 于公司〈2021 ...
利扬芯片: 关于2021年限制性股票激励计划首次授予部分第三个归属期归属结果暨股份上市的公告
Zheng Quan Zhi Xing· 2025-07-07 10:12
Core Points - The announcement details the results of the third vesting period of the 2021 Restricted Stock Incentive Plan for Guangdong Liyang Chip Testing Co., Ltd, with 573,441 shares set to be listed on July 11, 2025 [1][12] - The plan involves a total of 205 participants, with 2,389,445 shares granted, of which 573,441 shares are now vested [9][12] - The company has completed the necessary registration procedures for the shares, and the total share capital will increase from 202,434,834 to 203,008,275 shares [10][11] Summary by Sections Incentive Plan Overview - The board approved the 2021 Restricted Stock Incentive Plan on May 17, 2021, with independent directors confirming its benefits for the company's sustainable development [2][4] - The plan was publicly disclosed and approved by shareholders during a meeting on June 2, 2021 [3][4] Vesting Details - The third vesting period has a total of 573,441 shares, with 205 individuals eligible for the vesting [9][12] - The shares represent 24% of the total granted shares for the respective participants [9] Stock Listing and Flow - The shares will be listed for trading on July 11, 2025, and the company has outlined restrictions on the transfer of shares for directors and senior management [10][11] - The total share capital will increase to 203,008,275 shares following the vesting [10] Financial Impact - The company reported a net profit of -7.5845 million RMB for Q1 2025, with the basic earnings per share at -0.04 RMB; the new shares will dilute earnings based on the increased total share capital [11][12]
南芯科技: 关于2023年限制性股票激励计划第一个归属期归属结果暨股票上市公告
Zheng Quan Zhi Xing· 2025-06-20 10:49
Core Viewpoint - The announcement details the results of the first vesting period of the 2023 restricted stock incentive plan for Shanghai Nanchip Semiconductor Technology Co., Ltd, including the number of shares to be listed and the stock's circulation date [1][10]. Summary by Sections Incentive Plan Overview - The stock listing type is for equity incentive shares, with a total of 245,168 shares to be listed for circulation on June 20, 2025 [1][10]. - The company has completed the share registration for the first vesting period of the incentive plan for both the second category of incentive objects and the reserved grants for the first category [1][11]. Decision-Making Process - The board of directors and independent directors have approved the relevant proposals regarding the incentive plan, and the supervisory board has verified the list of incentive objects [3][6]. Vesting Details - For the second category of incentive objects, 11 individuals were granted a total of 360,973 shares, with 90,243 shares (25%) becoming vested [8]. - For the first category of incentive objects, 15 individuals were granted a total of 619,699 shares, with 154,925 shares (25%) becoming vested [8]. Stock Source and Listing Arrangements - The vested shares are sourced from the company's directed issuance of A-share common stock to the incentive objects [8]. - The total number of individuals receiving vested shares is 26 [8]. Capital Changes - The total share capital of the company increased from 425,457,743 shares to 425,702,911 shares following the vesting of the restricted stock [10]. - The number of unrestricted circulating shares increased by 245,168 shares [10]. Financial Impact - The company reported a net profit of RMB 63,492,563.31 for Q1 2025, with basic earnings per share of RMB 0.15. The vesting of shares will slightly dilute the earnings per share but is not expected to have a significant impact on the financial results [11].